Mriganka Sur

Mriganka Sur


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2012 in Nature
Verified
Journal Article
Closed access
PDF file
NWNathan R. Wilson
Nathan R. Wilson
CRCaroline A. Runyan
Caroline A. Runyan
FWForea L. Wang
Forea L. Wang
MSMriganka Sur
Mriganka Sur

4 November 2005 in Science
Verified
Journal Article
Closed access
PDF file
MSMriganka Sur
Mriganka Sur
JRJohn L. R. Rubenstein
John L. R. Rubenstein
The cerebral cortex of the human brain is a sheet of about 10 billion neurons divided into discrete subdivisions or areas that process particular aspects of sensation, movement, and cognition. Recent evidence has begun to transform our understanding of how cortical areas form, make specific connections with other brain regions, develop unique processing networks, and adapt to changes in inputs.

10 February 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
DTDaniela Tropea
Daniela Tropea
EGEmanuela Giacometti
Emanuela Giacometti
NWNathan R. Wilson
Nathan R. Wilson
CBCaroline Beard
Caroline Beard
CMCortina McCurry
Cortina McCurry
MSMriganka Sur
Mriganka Sur
Rett Syndrome (RTT) is a severe form of X-linked mental retardation caused by mutations in the gene coding for methyl CpG-binding protein 2 (MECP2). Mice deficient in MeCP2 have a range of physiological and neurological abnormalities that mimic the human syndrome. Here we show that systemic treatment of MeCP2 mutant mice with an active peptide fragment of Insulin-like Growth Factor 1 (IGF-1) extends the life span of the mice, improves locomotor function, ameliorates breathing patterns, and reduces irregularity in heart rate. In addition, treatment with IGF-1 peptide increases brain weight of the mutant mice. Multiple measurements support the hypothesis that RTT results from a deficit in synaptic maturation in the brain: MeCP2 mutant mice have sparse dendritic spines and reduced PSD-95 in motor cortex pyramidal neurons, reduced synaptic amplitude in the same neurons, and protracted cortical plasticity in vivo. Treatment with IGF-1 peptide partially restores spine density and synaptic amplitude, increases PSD-95, and stabilizes cortical plasticity to wild-type levels. Our results thus strongly suggest IGF-1 as a candidate for pharmacological treatment of RTT and potentially of other CNS disorders caused by delayed synapse maturation.

14 January 2019 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
VBVincent Breton-Provencher
Vincent Breton-Provencher
MSMriganka Sur
Mriganka Sur

21 October 2019 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
RSRianne D. Stowell
Rianne D. Stowell
GSGrayson O. Sipe
Grayson O. Sipe
RDRyan P. Dawes
Ryan P. Dawes
HBHanna N. Batchelor
Hanna N. Batchelor
KLKatheryn A. Lordy
Katheryn A. Lordy
AMAnia K. Majewska
Ania K. Majewska

27 April 2015 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
NCNaiyan Chen
Naiyan Chen
HSHiroki Sugihara
Hiroki Sugihara
MSMriganka Sur
Mriganka Sur
Cholinergic modulation of cortex powerfully influences information processing and brain states, causing robust desynchronization of local field potentials and strong decorrelation of responses between neurons. In this paper, the authors reveal a somatostatin-expressing inhibitory neuron-driven cortical circuit that mediates this change in the temporal structure of cortical dynamics. Cholinergic modulation of cortex powerfully influences information processing and brain states, causing robust desynchronization of local field potentials and strong decorrelation of responses between neurons. We found that intracortical cholinergic inputs to mouse visual cortex specifically and differentially drive a defined cortical microcircuit: they facilitate somatostatin-expressing (SOM) inhibitory neurons that in turn inhibit parvalbumin-expressing inhibitory neurons and pyramidal neurons. Selective optogenetic inhibition of SOM responses blocked desynchronization and decorrelation, demonstrating that direct cholinergic activation of SOM neurons is necessary for this phenomenon. Optogenetic inhibition of vasoactive intestinal peptide-expressing neurons did not block desynchronization, despite these neurons being activated at high levels of cholinergic drive. Direct optogenetic SOM activation, independent of cholinergic modulation, was sufficient to induce desynchronization. Together, these findings demonstrate a mechanistic basis for temporal structure in cortical populations and the crucial role of neuromodulatory drive in specific inhibitory-excitatory circuits in actively shaping the dynamics of neuronal activity.